Search
for

    Glossary Pharmacovigilance

    monitoring and evaluating drug safety to prevent adverse effects

    Pharmacovigilance, also known as Drug Safety Monitoring, is the science and activities involved in detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems. It aims to ensure that medicines are used safely and effectively, by collecting and analyzing data on side effects and other issues reported by healthcare professionals and patients.

    Research 10 of 416

    1. Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs International Journal of Environmental Research and Public Health · 2022 · 8 citations
    2. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase Journal of The American Academy of Dermatology · 2022 · 4 citations
    3. Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports Phytotherapy Research · 2023 · 2 citations
    4. Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil Zenodo (CERN European Organization for Nuclear Research) · 2026
    5. Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil Zenodo (CERN European Organization for Nuclear Research) · 2026
    6. Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database Frontiers in Public Health · 2026
    7. Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment Cronfa (Swansea University) · 2026
    8. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    9. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    10. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →